During the past decade, MD Clinical conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 48 clinical trials were completed, i.e. on average, 65.8% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 33 clinical trials were completed. i.e. 103.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Clinical" #1 sponsor was "Pfizer" with 17 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Janssen Vaccines & Prevention B.V." with 5 trials sponsored, "Merck Sharp & Dohme LLC" with 5 trials sponsored and "Jazz Pharmaceuticals" with 5 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Clinical" #1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "MD Clinical" are "Alzheimer's Disease" (28 trials), "Alzheimer Disease" (17 trials), "Parkinson Disease" (6 trials), "Parkinson's Disease" (6 trials) and "Depressive Disorder, Major" (5 trials). Many other conditions were trialed in "MD Clinical" in a lesser frequency.

Most popular intervention types in "MD Clinical" are "Drug" (104 trials), "Biological" (11 trials), "Other" (11 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (60 trials), "Ad26.COV2.S" (4 trials), "JZP-110" (4 trials), "placebo" (4 trials) and "Donepezil" (3 trials). Other intervention names were less common.

The vast majority of trials in "MD Clinical" are 113 trials for "All" genders.

Currently, there are NaN active trials in "MD Clinical". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in MD Clinical, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in MD Clinical, 30 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".